These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33092646)

  • 1. Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up.
    Klingberg E; Björkman S; Eliasson B; Larsson I; Bilberg A
    Arthritis Res Ther; 2020 Oct; 22(1):254. PubMed ID: 33092646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study.
    Klingberg E; Bilberg A; Björkman S; Hedberg M; Jacobsson L; Forsblad-d'Elia H; Carlsten H; Eliasson B; Larsson I
    Arthritis Res Ther; 2019 Jan; 21(1):17. PubMed ID: 30635024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention.
    Landgren AJ; Jonsson CA; Bilberg A; Eliasson B; Torres L; Dehlin M; Jacobsson LTH; Gjertsson I; Larsson I; Klingberg E
    Arthritis Res Ther; 2023 Jul; 25(1):131. PubMed ID: 37501212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study.
    Bilberg A; Larsson I; Björkman S; Eliasson B; Klingberg E
    Clin Rheumatol; 2022 Sep; 41(9):2745-2754. PubMed ID: 35648298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
    Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
    Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis.
    Fagni F; Mutlu MY; Temiz SA; Minopoulou I; Krieter M; Schett G; Kleyer A; Simon D; Hueber AJ
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life.
    Azevedo S; Santos-Faria D; Leite Silva J; Ramos Rodrigues J; Sousa Neves J; Peixoto D; Tavares-Costa J; Alcino S; Afonso C; Teixeira F
    Acta Reumatol Port; 2019; 44(4):322-324. PubMed ID: 32281967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
    McGonagle D; McInnes IB; Deodhar A; Schett G; Shawi M; Kafka S; Karyekar CS; Kollmeier AP; Hsia EC; Xu XL; Sheng S; Agarwal P; Zhou B; Ritchlin CT; Rahman P; Mease PJ
    Rheumatology (Oxford); 2021 Nov; 60(11):5337-5350. PubMed ID: 33822898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in cytokines and adipokines in obese patients with PsA and controls undergoing a weight loss intervention.
    Landgren AJ; Jonsson CA; Bilberg A; Eliasson B; Torres L; Dehlin M; Jacobsson L; Gjertsson I; Larsson I; Klingberg E
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38519111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
    Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
    Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound.
    Fiorenza A; Bonitta G; Gerratana E; Marino F; Sarzi-Puttini P; Salaffi F; Atzeni F
    Clin Exp Rheumatol; 2020; 38 Suppl 123(1):31-39. PubMed ID: 32116207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
    Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
    Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Cook RJ; Gladman DD
    Ann Rheum Dis; 2015 May; 74(5):813-7. PubMed ID: 24431392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
    Gladman DD; Orbai AM; Klitz U; Wei JC; Gallo G; Birt J; Rathmann S; Shrom D; Marzo-Ortega H
    Arthritis Res Ther; 2019 Jan; 21(1):38. PubMed ID: 30696483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.
    di Minno MN; Peluso R; Iervolino S; Lupoli R; Russolillo A; Scarpa R; di Minno G
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):141-7. PubMed ID: 22514189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years.
    Elnady B; El Shaarawy NK; Dawoud NM; Elkhouly T; Desouky DE; ElShafey EN; El Husseiny MS; Rasker JJ
    Clin Rheumatol; 2019 Jun; 38(6):1627-1635. PubMed ID: 30756253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of dietary interventions in psoriatic arthritis.
    Maharaj AB; Eder L; Ogdie A
    Curr Opin Rheumatol; 2023 Nov; 35(6):414-422. PubMed ID: 37339523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis.
    Nakagawa H; Tanaka Y; Sano S; Kameda H; Taniguchi A; Kashiwagi T; Kawaberi T; Kimura J; Morita A
    Adv Ther; 2019 Mar; 36(3):691-707. PubMed ID: 30661197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study.
    Adawi M; Damiani G; Bragazzi NL; Bridgewood C; Pacifico A; Conic RRZ; Morrone A; Malagoli P; Pigatto PDM; Amital H; McGonagle D; Watad A
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.
    Rahman P; Arendse R; Khraishi M; Sholter D; Sheriff M; Rampakakis E; Lehman AJ; Nantel F
    BMJ Open; 2020 Aug; 10(8):e036245. PubMed ID: 32792436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.